X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ALEMBIC PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB ALEMBIC PHARMA UNICHEM LAB/
ALEMBIC PHARMA
 
P/E (TTM) x 289.4 16.5 1,749.5% View Chart
P/BV x 0.7 4.4 15.0% View Chart
Dividend Yield % 2.5 0.8 331.1%  

Financials

 UNICHEM LAB   ALEMBIC PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
ALEMBIC PHARMA
Mar-18
UNICHEM LAB/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs382645 59.2%   
Low Rs234470 49.8%   
Sales per share (Unadj.) Rs116.3166.1 70.0%  
Earnings per share (Unadj.) Rs-18.921.9 -86.4%  
Cash flow per share (Unadj.) Rs-11.727.5 -42.7%  
Dividends per share (Unadj.) Rs5.004.00 125.0%  
Dividend yield (eoy) %1.60.7 226.2%  
Book value per share (Unadj.) Rs381.0117.8 323.5%  
Shares outstanding (eoy) m70.34188.52 37.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.63.4 78.9%   
Avg P/E ratio x-16.325.5 -64.0%  
P/CF ratio (eoy) x-26.220.3 -129.4%  
Price / Book Value ratio x0.84.7 17.1%  
Dividend payout %-26.418.3 -144.7%   
Avg Mkt Cap Rs m21,668105,090 20.6%   
No. of employees `0002.3NA-   
Total wages/salary Rs m2,0066,228 32.2%   
Avg. sales/employee Rs Th3,587.8NM-  
Avg. wages/employee Rs Th880.0NM-  
Avg. net profit/employee Rs Th-583.7NM-  
INCOME DATA
Net Sales Rs m8,18031,308 26.1%  
Other income Rs m61070 867.9%   
Total revenues Rs m8,79031,378 28.0%   
Gross profit Rs m-1,3206,431 -20.5%  
Depreciation Rs m5051,055 47.9%   
Interest Rs m8034 235.6%   
Profit before tax Rs m-1,2955,413 -23.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2-81 2.7%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m331,204 2.8%   
Profit after tax Rs m-1,3314,128 -32.2%  
Gross profit margin %-16.120.5 -78.6%  
Effective tax rate %-2.622.2 -11.6%   
Net profit margin %-16.313.2 -123.4%  
BALANCE SHEET DATA
Current assets Rs m23,31818,247 127.8%   
Current liabilities Rs m4,63511,235 41.3%   
Net working cap to sales %228.422.4 1,019.7%  
Current ratio x5.01.6 309.7%  
Inventory Days Days12286 142.3%  
Debtors Days Days12161 197.9%  
Net fixed assets Rs m8,16320,035 40.7%   
Share capital Rs m141377 37.3%   
"Free" reserves Rs m26,66021,824 122.2%   
Net worth Rs m26,80122,201 120.7%   
Long term debt Rs m35,000 0.1%   
Total assets Rs m31,89039,411 80.9%  
Interest coverage x-15.2160.2 -9.5%   
Debt to equity ratio x00.2 0.1%  
Sales to assets ratio x0.30.8 32.3%   
Return on assets %-3.910.6 -37.1%  
Return on equity %-5.018.6 -26.7%  
Return on capital %-4.519.7 -23.0%  
Exports to sales %046.4 0.0%   
Imports to sales %010.5 0.0%   
Exports (fob) Rs mNA14,535 0.0%   
Imports (cif) Rs mNA3,288 0.0%   
Fx inflow Rs m4,35614,722 29.6%   
Fx outflow Rs m07,026 0.0%   
Net fx Rs m4,3567,696 56.6%   
CASH FLOW
From Operations Rs m-1,1233,124 -36.0%  
From Investments Rs m16,487-8,844 -186.4%  
From Financial Activity Rs m-8,8115,026 -175.3%  
Net Cashflow Rs m6,552-693 -945.0%  

Share Holding

Indian Promoters % 50.1 74.1 67.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 2.9 520.7%  
FIIs % 3.0 9.1 33.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 13.9 228.1%  
Shareholders   20,176 49,328 40.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   FDC LTD.  ALEMBIC LTD  WYETH LTD  AJANTA PHARMA  SUVEN LIFESCIENCES  

Compare UNICHEM LAB With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Modi's Victory Creates Sensex History; Ache Din Ahead?(Podcast)

Throughout the week, one slogan that took over the market and country as a whole was, Ab ki baar phir Modi Sarkar.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9% (Quarterly Result Update)

May 9, 2019 | Updated on May 9, 2019

For the quarter ended March 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.6% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 61.0% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 11 bn (up 42.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

What Makes TVS Srichakra and CCL Products a Cut Above the Rest?(The 5 Minute Wrapup)

May 17, 2019

Despite the commodity nature of their businesses, these two stocks have rewarded shareholders well.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


May 24, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - ALEMBIC PHARMA COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS